United Kingdom of Great Britain and Northern Ireland
Tuberculosis profile
Population  2012 63 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.34 (0.34–0.34) 0.54 (0.54–0.55)
Mortality (HIV+TB only) 0.092 (<0.01–0.34) 0.15 (0–0.55)
Prevalence  (includes HIV+TB) 13 (5.4–23) 20 (8.7–36)
Incidence  (includes HIV+TB) 9.4 (8.8–10) 15 (14–16)
Incidence (HIV+TB only) 0.33 (0.25–0.41) 0.52 (0.4–0.66)
Case detection, all forms (%) 88 (82–94)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 1 251 (16) Relapse    
Smear-negative 1 204 (16) Treatment after failure    
Smear-unknown / not done 1 547 (20) Treatment after default    
Extrapulmonary 3 676 (48) Other 482 (100)
Other 53 (<1)      
Total new 7 731   Total retreatment 482  
           
Other (history unknown) 538        
Total new and relapse 7 731   Total cases notified 8 751  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.7 1.5 1.2
Age < 15 25 233 117
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 80   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 85  
Retreatment 80  
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.3 (1–1.7) 5.6 (3–9.3)
MDR-TB cases among notified pulmonary
TB cases
54 (42–70) 15 (8–25)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 4 570 (97%) 244 (51%) 5 151
Laboratory-confirmed MDR-TB cases 62 14 81
Patients started on MDR-TB treatment     84
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-17 Data: www.who.int/tb/data